The biopharmaceutics classification system

Comprehensive Medicinal Chemistry II

Volumn 5, Issue , 2006, Pages 971-988

  Lennernas H ^a   Abrahamsson, B ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649410856     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (127)

1. Amidon, G. L.; Lennernäs, H.; Shah, V. P; Crison, J. R. Pharm. Res. 1995, 12, 413-420.
2. CDER. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System; Food and Drug Administration: Rockville, MD, USA, 2000.
3. Yu, L. X.; Amidon, G. L.; Polli, J. E.; Zhao, H.; Mehta, M. U.; Conner, D. P; Shah, V P.; Lesko, L. J.; Chen, M. L.; Lee, V H.; Hussain, A. S. Pharm. Res. 2002, 19, 921-925.
4. Abrahamsson, B.; Lennernäs, H. Application of the Biopharmaceutic Classification System Now and in the Future. In. Drug Bioavailability, Estimation of Solubility, Permeability, Absorption and Bioavailability; van de Waterbeemd, H., Lennernäs, H., Artursson, P, Eds.; Wiley-VCH: Berlin, 2003, pp 493-531.
5. Polli, J. E.; Yu, L. X.; Cook, J. A.; Amidon, G. L.; Borchardt, R. T; Burnside, B. A.; Burton, P. S.; Chen, M. L.; Conner, D. P.; Faustino, P. J. et al. J. Pharm. Sci. 2004, 93, 1375-1381.
6. Lennernäs, H. J. Pharm. Sci. 1998, 87, 403-410.
7. Lennernäs, H.; Ahrenstedt, Ö.; Hällgren, R.; Knutson, L.; Ryde, M.; Paalzow, L. K. Pharm. Res. 1992, 9, 1243-1251.
8. Knutson, L.; Odlind, B.; Hallgren, R. Am. J. Gastroenterol. 1989, 84, 1278-1284.
9. Fleisher, D.; Li, C.; Zhou, Y; Pao, L. H.; Karim, A. Clin. Pharmacokinet. 1999, 36, 233-254.
10. Kasim, N. A.; Whitehouse, M.; Ramachandran, C.; Bermejo, M.; Lennernäs, H.; Hussain, A. S.; Amidon, G. L. Mol. Pharmaceut. 2004,1, 85-96.
11. Rowland, M.; Tozer, T N. Clinical Pharmacokinetics: Concepts and Applications, 3rd ed.; Williams & Wilkins: Philadelphia, PA, 1995, pp 119-134.
12. von Richter, O.; Greiner, B.; Fromm, M. F; Fraser, R.; Omari, T; Barclay, M. L.; Dent, J.; Somogyi, A. A.; Eichelbaum, M. Clin. Pharmacol. Ther. 2001, 70, 217-227.
13. Wu, C. Y; Benet, L. Z.; Hebert, M. F; Gupta, S. K.; Rowland, M.; Gomez, D. Y; Wacher, V J. Clin. Pharmacol. Ther. 1995, 58, 492-497.
14. CPMP:. Note for Guidance on the Investigation of Bioavailability and Bioequivalence (CPMP/EWP/QWP/1401/98); The European Agency for the Evaluation of Medicinal Products: London, UK, 2001.
15. Nakamura, T; Sakaeda, T; Ohmoto, N.; Tamura, T; Aoyama, N.; Shirakawa, T; Kamigaki, T; Nakamura, T; Kim, K. I.; Kim, S. R. et al. Drug. Metab. Dispos. 2002, 30, 4-6.
16. Berggren, S.; Lennernäs, P; Ekelund, M.; Weström, B.; Hoogstraate, J.; Lennernäs, H. J. Pharm. Pharmacol. 2003, 55, 963-972.
17. de Waziers, I.; Cugnenc, P H.; Yang, C. S.; Leroux, J. P; Beaune, P. H. J. Pharmacol. Exp. Ther. 1990, 253, 387-394.
18. Goldin, B. R. Ann. Med. 1990, 22, 43-48.
19. Chandra, P; Brouwer, K. L. Pharm. Res. 2004, 21, 719-735.
20. Tannergren, C.; Petri, N.; Knutson, L.; Hedeland, M.; Bondesson, U.; Lennernäs, H. Clin. Pharmacol. Ther. 2003, 74, 423-436.
21. Rekhi, G. S.; Eddington, N. D.; Fossler, M. J.; Schwartz, P; Lesko, L. J.; Augsburger, L. L. Pharm. Devel. Technol. 1997, 2, 11-24.
22. Bogman, K.; Zysset, Y; Degen, L.; Hopfgartner, G.; Gutmann, H.; Alsenz, J.; Drewe, J. Clin. Pharmacol. Ther. 2005, 77, 24-32.
23. Lennernäs, H.; Gjellan, K.; Hällgren, R.; Graffner, C. J. Pharm. Pharmacol. 2002, 54, 499-508.
24. Adkin, D. A.; Davis, S. S.; Sparrow, R. A.; Huckle, P. D.; Phillips, A. J.; Wilding, I. R. Br. J. Clin. Pharmacol. 1995, 39, 381-387.
25. Basit, A. W; Podczeck, F; Newton, J. M.; Waddington, W A.; Ell, P. J.; Lacey, L. F. Eur. J. Pharm. Sei. 2004, 21, 179-189.
26. CDER:. Immediate-Release Solid Oral Dosage Forms: Scale-Up and Post-Approval Changes: Chemistry, Manufacturing and Controls, In vitro Dissolution Testing, and In vivo Bioequivalence Documentation; Food and Drug Administration: Rockville, MD, USA, 1995.
27. Q6A International Conference on Harmonisation; Guidance on Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. Rockville, MD, USA, 2000.
28. Van de Waterbeemd, H.; Smith, D. A.; Beaumont, K.; Walker, D. K. J. Med. Chem. 2001, 44, 1313-1333.
29. Van de Waterbeemd, H.; Gifford, E. Nat. Rev. Drug. Disc. 2003, 2, 192-204.
30. Lajiness, M. S.; Vieth, M.; Erickson, J. Curr. Opin. Drug. Disc. Devel. 2004, 7, 457-470.
31. Kola, I.; Landis, J. Nat. Rev. Drug Disc. 2004, 3, 711-716.
32. van de Waterbeemd, H. Eur. J. Pharm. Sci. 1998, 7, 1-3.
33. Lipinski, C. A.; Lombardo, F; Dominy, B. W; Feeney, P J. Adv. Drug Deliv. Rev. 2001, 46, 3-26.
34. Egan, W J.; Lauri, G. Adv. Drug. Deliv. Rev. 2002, 31, 273-289.
35. Volpe, D. A. Pharm. Sci. 2004, 6, 1-6.
36. Sun, D.; Lennernäs, H.; Welage, L. S.; Barnett, J. L.; Landowski, C. P; Foster, D.; Fleisher, D.; Lee, K.-D.; Amidon, G. L. Pharm. Res. 2002, 19, 1400-1416.
37. Lennernäs, H.; Palm, K.; Fagerholm, U.; Artursson, . P Int. J. Pharm. 1996, 127, 103-107.
38. Lennernäs, H. J. Pharm. Pharmacol. 1997, 49, 627-638.
39. Lennernaas, H. J. Pharm. Pharmacol. 2003, 55, 429-433.
40. Chiou, W L.; Chung, S. M.; Wu, T C.; Ma, C. Int. J. Clin. Pharmacol. Ther. 2001, 39, 93-101.
41. Petri, N.; Tannergren, C.; Rungstad, D.; Lennernäs, H. Pharm. Res. 2004, 21, 1398-1404.
42. Tannergren, C.; Knutson, T; Knutson, L.; Lennernäs, H. Br. J. Clin. Pharmacol. 2003, 55, 182-190.
43. van Montfoort, J. E.; Hagenbuch, B.; Groothuis, G. M.; Koepsell, H.; Meier, P. J.; Meijer, D. F. Curr. Drug Metab. 2003, 4, 185-211.
44. Mizuno, N.; Niwa, T; Yotsumoto, Y; Sugiyama, Y. Pharmacol. Rev. 2003, 55, 425-461.
45. Winiwarter, S.; Bonham, N.; Hallberg, A.; Lennernäs, H.; Karlen, A. J. Med. Chem. 1999, 41, 4939-4949.
46. Winiwarter, S.; Ax, F; Lennernäs, H.; Hallberg, A.; Pettersson, C.; Karlén, A. J. Mol. Graph. Model. 2003, 21, 283-287.
47. Bergstrom, C. A.; Norinder, U.; Luthman, K.; Artursson, P. J. Chem. Inf. Comput. Sei. 2003, 43, 1177-1185.
48. Fichert, T.; Yazdanian, M.; Proudfoot, J. R. Bioorg. Med. Chem. Lett. 2003, 13, 719-722.
49. Sanghvi, T; Jain, N.; Yang, G.; Yalkowsky, S. H. QSAR Combin. Sei. 2003, 22, 258-262.
50. Agoram, B.; Woltosz, W S.; Bolger, M. B. Adv. Drug Deliv. Rev. 2001, 50, S41-S67.
51. Grass, G. M.; Sinko, P. J. Adv. Drug Deliv. Rev. 2002, 54, 433-451.
52. Rowland, M., Balant, L., Peck, C., . PharmSci. 2004, 09; 6, E6.
53. Lindahl, A.; Sjöberg, Å.; Bredberg, U.; Toreson, H.; Ungell, A. L.; Lennernäs, H. Mol. Pharmaceut. 2004, 1, 347-356.
54. Bermejo, M.; Avdeef, A.; Ruiz, A.; Nalda, R.; Ruell, J. A.; Tsinman, O.; Gonzalez, I.; Fernandez, C.; Sanchez, G.; Garrigues, T M.; Merino, V. Eur. J. Pharm. Sei. 2004, 21, 429-441.
55. Obata, K. M.; Sugano, K.; Machida, M.; Aso, Y. Drug Dev. Ind. Pharm. 2004, 30, 181-185.
56. Fagerholm, U.; Johansson, M.; Lennernäs, H. Pharm. Res. 1996, 13, 1335-1341.
57. Fagerholm, U.; Lindahl, A.; Lennernäs, H. J. Pharm. Pharmacol. 1997, 49, 687-690.
58. Fagerholm, U.; Nilsson, D.; Knutson, L.; Lennernäs, H. Acta Physiol. Scand. 1999, 165, 315-324.
59. Ungell, A. L.; Nylander, S.; Bergstrand, S.; Sjäberg, Å.; Lennernäs, H. J. Pharm. Sei. 1998, 87, 360-366.
60. Chiou, W L.; Barve, A. Pharm. Res. 1998, 11, 1792-1795.
61. Berggren, S.; Hoogstraate, J.; Fagerholm, U.; Lennernäs, H. Eur. J. Pharm. Sei. 2004, 21, 553-560.
62. Corrigan, O. I. Adv. Exp. Med. Biol. 1997, 423, 111-128.
63. Anderson, C. M.; Grenade, D. S.; Boll, M.; Foltz, M.; Wake, K. A.; Kennedy, D. J.; Munck, L. K.; Miyauchi, S.; Taylor, P M.; Campbell, F C. et al. Gastroenterol. 2004, 127, 1410-1422.
64. Chiou, W L.; Jeong, H. Y; Chung, S. M.; Wu, T C. Pharm. Res. 2000, 17, 135-140.
65. Dressman, J. B.; Yamada, K. Animal Models for Oral Drug Absorption. In. Pharmaceutical bioequivalence; Welling, P G., Tse, F L. S., Dighe, S. V, Eds.; Marcel Dekker: New York, 1991, pp 235-266.
66. Kararli, T T. Biopharm. Drug Disp. 1995, 16, 351-380.
67. Ritschel, W A. Sei. Tech. Prat. Pharm. 1987, 3, 125-141.
68. Persson, E.; Carlsson, A.; Gustafsson, A. S.; Knutsson, L.; Lennernäs, H.; Abrahamsson B. Pharm. Res. 2005, 22, 2141-2151.
69. Hu, J.; Johnston, K. P; Williams, R. O., III. Drug Dev. Indust. Pharm. 2004, 30, 233-245.
70. Patravale, V B.; Abhijit, A.; Kulkarni, R. M. J. Pharm. Pharmacol. 2004, 56, 827-840.
71. Wu, Y; Loper, A.; Landis, E.; Hettrick, L.; Novak, L.; Lynn, K.; Chen, C.; Thompson, K.; Higgins, R.; Batra, U. et al. Int. J. Pharm. 2004, 285, 135-146.
72. Kim, C.-K.; Park, J.-S. Am. J. Drug. Deliv. 2004, 2, 113-130.
73. Fagerholm, U.; Sjöström, B.; Sroka-Markovic, J.; Wijk, A.; Svensson, M.; Lennernäs, H. J. Pharm. Pharmacol. 1998, 50, 467-473.
74. Schipper, N. G. M.; Vårum, K. M.; Stenberg, P; Ocklind, G.; Lennernäs, H.; Artursson, . P. Eur. J. Pharm. Sei. 1999, 8, 335-343.
75. Kato, Y; Onishi, H.; Machida, Y. Curr. Pharm. Biotechnol 2003, 4, 303-309.
76. Mahato, R. I.; Narang, A. S.; Thoma, L.; Miller, D. D. Crit. Rev. Ther. Drug Carrier. Syst. 2003, 20, 153-214.
77. Mrestani, Y; Bretschneider, B.; Hartl, A.; Neubert, R. H. J. Pharm. Pharmacol. 2003, 55, 1601-1606.
78. Uchiyama, T; Sugiyama, T; Quan, Y S.; Kotani, A.; Okada, N.; Fujita, T; Muranishi, S.; Yamamoto, A. J. Pharm. Pharmacol. 1999, 51, 1241-1250.
79. Ettmayer, P; Amidon, G. L.; Clement, B.; Testa, B. J. Med. Chem. 2004, 47, 2393-2404.
80. Eriksson, B. I.; ArfWidsson, A. C.; Frison, L.; Eriksson, U. G.; Bylock, A.; Kälebo, P.; Fager, G.; Gustafsson, D. Thromb. Haemost. 2002, 87, 231-237.
81. Eriksson, U. G.; Bredberg, U.; Hoffmann, K.-J.; Thuresson, A.; Gabrielsson, M.; Ericsson, H.; Ahnoff, M.; Gislen, K.; Fager, G.; Gustafsson, D. Drug Metab. Disp. 2003, 31, 294-305.
82. Steffansen, B.; Nielsen, C. U.; Brodin, B.; Eriksson, A. H.; Andersen, R.; Frokjaer, S. Eur. J. Pharm. Sei. 2004, 21, 3-16.
83. Thomsen, A. E.; Friedrichsen, G. M.; Sorensen, A. H.; Andersen, R.; Nielsen, C. U.; Brodin, B.; Begtrup, M.; Frokjaer, S.; Steffansen, B. J. Contr. Release 2003, 86, 279-292. Erratum in: J. Contr. Release 2003, 88, 343.
84. Beauchamp, L. M.; Orr, G. F; De Miranda, P; Burnette, T; Krenitsky, T A. Antiviral Chem. Chemother. 1992, 3, 157-164.
85. Han, H. K.; De Vrueh, R. L. A.; Rhie, J. K.; Covitz, K.-M. Y; Smith, P. L.; Lee, C.-P; Oh, D.-M.; Sadee, W; Amidon, G. L. Pharm. Res. 1998, 15, 1154-1159.
86. Swaan, P. W; Tukker, J. J. J. Pharm. Sei. 1997, 86, 596-602.
87. Connor, A. L.; Wray, H.; Cottrell, J.; Wilding, I. R. Eur. J. Pharm. Sei. 2001, 13, 369-374.
88. Oh, D. M.; Sinko, P. J.; Amidon, G. L. J. Pharm. Sci. 1993, 82, 897-900.
89. Lennernäs, H.; Knutson, L.; Knutson, T; Hussain, A.; Lesko, L.; Salomonsson, T; Amidon, G. L. Eur. J. Pharm. Sei. 2002, 15, 271-277.
90. Barr, W H.; Zola, E. M.; Candler, E. L.; Hwang, S. M.; Tendolkar, A. V; Shamburek, R.; Parker, B.; Hilty, M. D. Clin. Pharmacol. Ther. 1994,56, 279-285.
91. Gottfries, J.; Svenheden, A.; Alpsten, M.; Bake, B.; Larsson, A.; Idstrom, J.-P. Scand. J. Gastroenterol. 1996, 31, 49-53.
92. Klausner, E. A.; Lavy, E.; Friedman, M.; Hoffman, A. J. Contr. Release 2003, 90, 143-162.
93. Abrahamsson, B.; Johansson, D.; Torstensson, A.; Wingstrand, K. Pharm. Res. 1994, 11, 1093-1097.
94. Grunda, J. S.; Foster, R. T. Clin. Pharmacokinet. 1996, 30, 28-51.
95. Bonlokke, L.; Hovgaard, L.; Kristensen, H. G.; Knutson, L.; Lennernäs, H. Eur. J. Pharm. Sei. 2001, 12, 239-250.
96. Kossena, G. A.; Charman, W. N.; Boyd, B. J.; Dunstan, D. E.; Porter, C. J. J. Pharm. Sci. 2004, 93, 332-348.
97. Porter, C. J.; Kaukonen, A. M.; Taillardat-Bertschinger, A.; Boyd, B. J.; O'Connor, J. M.; Edwards, G. A.; Charman, W N. J. Pharm. Sei. 2004, 93, 1110-1121.
98. Kostewicz, E. S.; Brauns, U.; Becker, R.; Dressman, J. B. Pharm. Res. 2002, 19, 345-349.
99. Scholz, A.; Kostewicz, E.; Abrahamsson, B.; Dressman, J. B. J. Pharm. Pharmacol. 2003, 55, 443-451.
100. Edgar, B.; Bailey, D.; Bergstrand, R.; Johnsson, G.; Regardh, C. G. Eur. J. Clin. Pharmacol. 1992, 42, 313-317.
101. Charman, W. N.; Porter, C. J.; Mithani, S.; Dressman, J. B. J. Pharm. Sci. 1997, 86, 269-282.
102. Sunesen, V H.; Vedelsdal, R.; Kristensen, H. G.; Christrup, L.; Mullertz, A. Eur. J. Pharm. Sei. 2005, 24, 297-303.
103. Dressman, J. B.; Berardi, R. R.; Dermentzoglou, L. C.; Russell, T L.; Schmaltz, S. P; Barnett, J. L.; Jarvenpaa, K. M. Pharm. Res. 1990, 7, 756-761.
104. Lindahl, A.; Ungell, A.-L.; Lennernäas, H. Pharm. Res. 1997, 14, 497-502.
105. Gleiter, C. H.; Morike, K. E. Clin. Pharmacokinet. 2002, 41, 7-17.
106. Sarna, S. K. Gastroenterology 1985, 89, 894-913.
107. Oberle, R. L.; Chen, T S.; Lloyd, C.; Barnett, J. L.; Owyang, C.; Meyerand, J.; Amidon, G. L. Gastroenterology 1990, 99, 1275-1282.
108. Ziessman, H. A.; Fahey, F H.; Collen, M. J. Dig. Dis. Sei. 1992, 37, 744-750.
109. Yu, L. X.; Straughn, A. B.; Faustino, P. J.; Yang, Y; Parekh, A.; Ciavarella, A. B.; Asafu-Adjaye, E.; Mehta, M. U.; Conner, D. P; Lesko, L. J.; Hussain, A. S. Mol. Pharmaceut. 2004, 5, 357-362.
110. Davis, S. S.; Hardy, J. G.; Fara, J. W. Gut 1986, 27, 886-892.
111. Lennernäs, H.; Nilsson, D.; Aquilonius, S.-M.; Ahrenstedt, O.; Knutson, L.; Paalzow, L. K. Br. J. Clin. Pharmacol. 1993, 35, 243-250.
112. Shiraga, T; Miyamoto, K.; Tanaka, H.; Yamamoto, H.; Taketani, Y; Morita, K.; Tamai, I.; Tsuji, A.; Takeda, E. Gastroenterology 1999, 116, 354-362.
113. Thamotharan, M.; Bawani, S. Z.; Zhou, X.; Adibi, S. A. Am. J. Physiol. 1999, 276, C821-C826.
114. Howard, A.; Goodlad, R. A.; Walters, J. R.; Ford, D.; Hirst, B. H. J. Nutr. 2004, 134, 2957-2964.
115. Yazdanian, M.; Briggs, K.; Jankovsky, C.; Hawi, A. Pharm. Res. 2004, 21, 293-299.
116. Kostewicz, E. S.; Wunderlich, M.; Brauns, U.; Becker, R.; Bock, T; Dressman, J. B. J. Pharm. Pharmacol. 2004, 56, 43-51.
117. Rinaki, E.; Dokoumetzidis, A.; Valsami, G.; Macheras, . P. Pharm. Res. 2004, 21, 1567-1572.
118. Klein, S.; Butler, J.; Hempenstall, J. M.; Reppas, C.; Dressman, J. B. J. Pharm. Pharmacol. 2004, 56, 605-610.
119. Blume, H. H.; Schug, B. S. Eur. J. Pharm. Sci. 1999, 9, 117-121.
120. Yu, L. X.; Ellison, C. D.; Conner, D. P.; Lesko, L. J.; Hussain, A. S. PharmSci. 2001, 3, E24.
121. Cheng, C. L.; Yu, L. X.; Lee, H. L.; Yang, C. Y; Lue, C. S.; Chou, C. H. Eur. J. Pharm. Sci. 2004, 22, 297-304.
122. Vogelpoel, H.; Welink, J.; Amidon, G. L.; Junginger, H. E.; Midha, K. K.; Moller, H.; Olling, M.; Shah, V P; Barends, D. M. J. Pharm. Sci. 2004, 93, 1945-1956.
123. Lindahl, A.; Sandstrom, R.; Ungell, A.-L.; Abrahamsson, B.; Knutson, L.; Knutson, T; Lennernäs, H. Clin. Pharm. Ther. 1996, 60, 493-503.
124. Petri, N.; Lennernäs, H. In Vivo Permeability Studies in the GI Tract. In. Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability; van de Waterbeemd, H., Lennernäs, H., Artursson, P., Eds.; Wiley-VCH: Weinheim, Germany, 2004, pp 345-386.
125. Sandström, R.; Karlsson, A.; Knutson, L.; Lennernäs, H. Pharm. Res. 1998, 15, 856-862.
126. Wu, C.-Y; Benet, L. Z. Pharm. Res. 2005, 22, 11-23.
127. Food and Drug Administration. http://www.fda.gov/cder/guidance/3618fnl.htm (accessed July 2006).